NCT05236465Recruiting
A 3-day Course for CFS/ME
A 3-day Course for Adults With Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME): a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 26 Nov 2025
Brief summary (registry, in English)
Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatically affected. CFS/ME is a challenging health problem as well as a societal problem. In recent years, a doubling of the number of patients with a CFS/ME diagnoses has been reported in Norway. The patient group represents a challenge for the health care system, the municipality, and the Norwegian Labour and Welfare Organization (NAV). According to new figures, the NAV pays 100 million Norwegian Kroner (NOK) each month in permanently incapacitated expenses for people with CFS/ME. Municipalities have expenses in form of care, rehabilitation and other measures. There is a lack of effective treatment for CFS/ME. Evidence-based knowledge is highly needed. If the 3-day course shows promising effects, this could have positive consequences for patients, relatives and health personnel, but also financially for the society and the municipality.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 4 Feb 2022
- Start date
- 21 Mar 2022
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- Norwegian University of Science and Technology
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05236465
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 21 Mar 2022 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Suicide risk/previous suicide attempts.
Other illness
- Underlying physical illness or mental disorder that may explain the symptoms.
Other
- Assessed by a General Practitioner (GP):
- Pregnancy.
- Bedridden and in need of continuous care.
- Insufficient Norwegian speaking or writing skills to participate in the 3-day course and fill out questionnaires.
Who the study is looking for
- CFS/ME diagnosis based on the Canada Consensus Criteria.
- At least 50% out of school/work.
- Readiness to change (corresponding to the preparation phase in transtheoretical model)
- Has given informed consent.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Psychology, NTNU Coordinator of this site? Confirm its status | Trondheim | Norway | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.